Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
‘We believe in America’: Nike global vp of soccer Camilo Andrade on the brand’s World Cup strategy
Under the leadership of new CEO Elliott Hill, Nike has been enacting a new strategy called the “Sport Offense.”
OpenAI moves to automate ad creative
OpenAI wants to automate the last thing advertisers still do themselves.
‘Don’t walk past the Gutter Bar’: The unofficial Cannes Lions survival guide, written in hindsight
What happens on the Croisette apparently happens to everyone.